Literature DB >> 24805106

The NLRP3/ASC inflammasome promotes T-cell-dependent immune complex glomerulonephritis by canonical and noncanonical mechanisms.

Kirstin Andersen1, Nuru Eltrich1, Julia Lichtnekert1, Hans-Joachim Anders1, Volker Vielhauer1.   

Abstract

Interleukin (IL)-1β contributes to renal injury in immune complex glomerulonephritis. However, production of mature IL-1β depends on activation of the inflammasome that cleaves pro-IL-1β into its secretable form. A functional role of the NLRP3-containing inflammasome, which responds to various endogenous danger signals, was found in tubulointerstitial nephropathies, but its function in glomerular disease has not been established. To determine whether NLRP3 and its adapter molecule ASC contribute to glomerulonephritis, we induced T-cell-dependent autologous nephrotoxic serum nephritis in Nlrp3- and Asc-deficient mice. Renal expression of NLRP3/ASC inflammasome components and pro-IL-1β increased during nephrotoxic serum nephritis and was abundant in renal dendritic cells. This was associated with renal production of mature IL-1β, indicating inflammasome activation. Nlrp3 and Asc deficiency significantly attenuated glomerular injury, renal leukocyte infiltration, and T-cell activation. Production of mature IL-1β was abrogated in Asc-deficient mice, consistent with a loss of inflammasome-dependent IL-1β activation. Surprisingly, renal IL-1β secretion remained intact in Nlrp3-deficient mice, indicating noncanonical pro-inflammatory effects of NLRP3 in autologous nephrotoxic serum nephritis. This may include NLRP3-mediated glomerular release of pro-inflammatory high-mobility group box 1 protein as a noncanonical function of NLRP3/ASC in glomerulonephritis. Thus, therapeutic blockade of the NLRP3/ASC/IL-1β axis may be beneficial in glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24805106     DOI: 10.1038/ki.2014.161

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

1.  Upregulation of NLRP3 inflammasome components in Mooren's ulcer.

Authors:  Zhiyuan Li; Chao Wei; Shuang Wang; Ting Liu; Hualei Zhai; Weiyun Shi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-28       Impact factor: 3.117

Review 2.  Inflammation and hypertension: new understandings and potential therapeutic targets.

Authors:  Carmen De Miguel; Nathan P Rudemiller; Justine M Abais; David L Mattson
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

Review 3.  Inflammasome Activation in Chronic Glomerular Diseases.

Authors:  Sabena M Conley; Justine M Abais; Krishna M Boini; Pin-Lan Li
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

4.  Egr-1 deficiency protects from renal inflammation and fibrosis.

Authors:  Li-Chun Ho; Junne-Ming Sung; Yi-Ting Shen; Huei-Fen Jheng; Shun-Hua Chen; Pei-Jane Tsai; Yau-Sheng Tsai
Journal:  J Mol Med (Berl)       Date:  2016-03-09       Impact factor: 4.599

5.  The Expression Changes of Inflammasomes in the Aging Rat Kidneys.

Authors:  Fei Song; Yuxiang Ma; Xue-Yuan Bai; Xiangmei Chen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-07-28       Impact factor: 6.053

Review 6.  Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease.

Authors:  Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2016-08-11       Impact factor: 10.121

7.  Role of NLRP3 Inflammasomes for Rhabdomyolysis-induced Acute Kidney Injury.

Authors:  Takanori Komada; Fumitake Usui; Akira Kawashima; Hiroaki Kimura; Tadayoshi Karasawa; Yoshiyuki Inoue; Motoi Kobayashi; Yoshiko Mizushina; Tadashi Kasahara; Shun'ichiro Taniguchi; Shigeaki Muto; Daisuke Nagata; Masafumi Takahashi
Journal:  Sci Rep       Date:  2015-06-05       Impact factor: 4.379

8.  Upregulation of NLRP3 Inflammasome in the Tears and Ocular Surface of Dry Eye Patients.

Authors:  Liangliang Niu; Shujie Zhang; Jihong Wu; Ling Chen; Yan Wang
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

9.  NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy.

Authors:  Yu-Ling Tsai; Kuo-Feng Hua; Ann Chen; Chyou-Wei Wei; Wen-Shiang Chen; Cheng-Yeu Wu; Ching-Liang Chu; Yung-Luen Yu; Chia-Wen Lo; Shuk-Man Ka
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

10.  Tumor necrosis factor superfamily ligand mRNA expression profiles differ between humans and mice during homeostasis and between various murine kidney injuries.

Authors:  Satish Kumar Devarapu; Julia Felicitas Grill; Junhui Xie; Marc Weidenbusch; Mohsen Honarpisheh; Volker Vielhauer; Hans-Joachim Anders; Shrikant R Mulay
Journal:  J Biomed Sci       Date:  2017-09-19       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.